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ABSTRACT
Obesity represents a risk factor for development of insulin resistance and type 2 diabetes. In addition, it has been associated with
increased adipocyte formation in the bonemarrow (BM) alongwith increased risk for bone fragility fractures. However, little is known
on the cellularmechanisms that link obesity, BM adiposity, and bone fragility. Thus, in an obesity intervention study in C57BL/6Jmice
fed with a high-fat diet (HFD) for 12 weeks, we investigated the molecular and cellular phenotype of bone marrow adipose tissue
(BMAT), BM progenitor cells, and BM microenvironment in comparison to peripheral adipose tissue (AT). HFD decreased trabecular
bonemass by 29%, cortical thickness by 5%, and increased BM adiposity by 184%. In contrast to peripheral AT, BMAT did not exhibit
pro-inﬂammatory phenotype. BM progenitor cells isolated from HFDmice exhibited decreased mRNA levels of inﬂammatory genes
(Tnfa, IL1b, Lcn2) and did not manifest an insulin resistant phenotype evidenced by normal levels of pAKT after insulin stimulation as
well as normal levels of insulin signaling genes. In addition, BM progenitor cells manifested enhanced adipocyte differentiation in
HFD condition. Thus, our data demonstrate that BMAT expansion in response to HFD exerts a deleterious effect on the skeleton.
Continuous recruitment of progenitor cells to adipogenesis leads to progenitor cell exhaustion, decreased recruitment to
osteoblastic cells, and decreased bone formation. In addition, the absence of insulin resistance and inﬂammation in the BM suggest
that BMAT buffers extra energy in the form of triglycerides and thus plays a role in whole-body energy homeostasis. © 2018 The
Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.
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Introduction
Obesity is a major health problem worldwide and representsa signiﬁcant risk factor for insulin resistance, type 2
diabetes (T2D), and cardiovascular diseases.(1) Recent epidemi-
ological studies have reported an association between obesity
and increased risk of fragility fractures.(2)However, the biological
mechanisms underlying this phenomenon are not known.
In addition to the expansionof peripheral adipose tissue (AT) in
obesity, a similar expansion in bone marrow adipose tissue
(BMAT) takes place.(3,4) BMAT is a newly recognized endocrine-
active fat depot that is present in the non-hematopoietic marrow
and in close contact with hematopoietic and bone tissues.(5,6)
BMAT responds tometabolic needs of the organism as evidenced
by signiﬁcant expansion in a number of pathophysiological
conditions, e.g., aging, diabetes, obesity, and anorexia nervosa or
during pharmacological treatment with thiazolidinediones,
glucocorticoids, or chemotherapy.(3,4,7–9) BMAT originates from
the bone marrow skeletal (also known as stromal or mesenchy-
mal) stem cells (BM-MSC) present in the bone marrow (BM)
stroma. BM-MSC give rise, in addition to adipocytes, to
osteoblasts and hematopoietic-supporting stroma.(9) The differ-
entiation capacity of BM-MSC is regulated via several secreted
factors (e.g., sFRP-1, Dlk1/Pref-1), immune molecules (e.g.,
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interleukins, TNFa,(10) microRNAs(11)), and systemic hormones
(e.g., parathyroid hormone(12) and insulin-like growth factors(13))
present within the BM-MSC niche, which dictate lineage
fate.(5,14,15)Moreover, BM-MSC lie in the vicinity of hematopoietic
stem cells (HSC), whose microenvironment is affected in obesity
and thus may participate in the regulation of BM-MSC differenti-
ation and bone homeostasis.(16–19) However, the possible
relationship between increased BM adiposity, bone mass, and
bone fragility are not completely determined.
Despite increased attention on the regulation of bone versus fat
formation in the BM as a regulatory factor for bone formation, little
is known regarding the metabolic function of BMAT and its
contribution to whole-body energymetabolism. Although there is
extensive literature on the role of visceral, subcutaneous, and
brown adipose depots (VAT, SAT, BAT, respectively) in the
development of insulin resistance and T2D, few studies have
investigated the function of BMAT as an adipose storage
organ.(6,8,20,21) In obesity and T2D, peripheral AT develops insulin
resistance and exhibits impaired insulin signaling.(22) However,
there is no clear information about insulin sensitivity in BMAT.(23,24)
In the current study, we hypothesized that obesity leads to
metabolic changes in the BMmicroenvironment affecting BM-MSC
biology,BMATphenotype, and skeletal homeostasis.Usingamouse
model of high-fat diet (HFD)–induced obesity, we investigated
changes in bone mass, bone marrow fat mass, as well as the
molecular phenotype and insulin sensitivity of BMAT and BM-MSC
as comparedwithperipheral AT.Wedemonstrated that in response
to HFD, there is an expansion in BMAT volume that is associated
with decreasedbonemass and impaired differentiation of BM-MSC.
Materials and Methods
Additional procedures are described in the Supplemental Data.
Animals
Male C57BL/6J mice (Taconic, Rensselaer, NY, USA) were given
ad libitum normal chow diet (Altromin [Lage, Germany] 132003,
containing 6% fat, 30% protein, 63% carbohydrate, 7.7%
sucrose) or 60 kcal% high-fat diet (Research Diet [New
Brunswick, NJ, USA] D12492, containing 35% fat, 26% protein,
26% carbohydrate, 8.8% sucrose) at 8 weeks of age for a period
of 12 or 20 weeks. Animals were bred and housed under
standard conditions (21°C, 55% relative humidity) on a 12-hour
light/dark cycle. All experimental procedures were approved by
the Danish Animal Ethical committee (2017-15-0201-01210).
Micro-computed tomography scanning (mCT)
Proximal tibias of mice fed for 12 weeks with HFD or with normal
diet (ND) as control were scanned with a high-resolution mCT
system (vivaCT40; Scanco Medical, Bassersdorf, Switzerland),
resulting in three-dimensional (3D) reconstruction of cubic voxel
sizes 10.5 10.5 10.5mm3. A detailed description for the
quantiﬁcation of 3D microarchitecture of trabecular and cortical
bone has been presented previously.(25)
Isolation of bone marrow skeletal stem cells (BM-MSC)
and hematopoietic stem cells (HSC)
BM-MSC were isolated from the bones of front and hind limbs of
C57BL/6J male mice (after 12 weeks of HFD) following the
protocol of Zhu and colleagues and Houlihan and col-
leagues(26,27) with a slight modiﬁcation. After bone crushing, a
collagenase digestion (StemCell, Vancouver, Canada; 5%
collagenase) and negative selection of CD45, CD31, and
Ter119 cells was done to obtain BM-MSC. The positive fraction
with hematopoietic stem cells (HSC) was also kept for further
analysis. Cells were cultivated and expanded in vitro up to
passage 3. The BM-MSC were pooled from 2 mice in each group
and used for subsequent analyses.
Isolation of bone marrow adipose tissue (BMAT)
BMAT were isolated from long bones based on the protocol of
Liu and colleagues and Lanske and colleagues by ﬂushing the
BM, quick high-speed spinning, and removing HSC.(28,29) Then
the pellets containing the BMAT and HSC were resuspended in
phosphate buffered saline (PBS) to let BMAT ﬂoat on the top of
the liquid suspension. HSC pellet was lysedwith erythrocyte lysis
buffer to remove red blood cells.
Isolation of adipose-derived stromal (mesenchymal)
stem cells (AT-MSC)
Epididymal fat pads were mechanically dissociated using the
gentleMACS Dissociator (Miltenyi Biotec, Bergisch Gladbach,
Germany) and collagenase digested at 37°C for 45 minutes in
HBSS (Gibco, Life Technologies, Carlsbad, CA, USA) containing
2% BSA (American Bioanalytical, Natick, MA, USA) and 1%
collagenase (Sigma-Aldrich, St. Louis, MO, USA). Samples were
ﬁltered through 300-mm-diameter pore nylon mesh and
centrifuged. The adipocyte layer and the supernatant were
aspirated and the pelleted cells were collected as the stromal-
vascular fraction (SVF) containing AT-MSC. The cells were then
treated with red blood cell lysis buffer and washed with PBS and
plated or directly harvested for further analysis. The cells were
then plated at a density of 200,000 cells/well in 6-well plates.
Dynamic bone histomorphometry
Mice were injected with calcein 30mg/kg (Fluka Chemie, Buchs,
Switzerland) at 9 and 2 days, respectively, before euthanasia.
OsteoMeasure analysis software (OsteoMetrics, Decatur, GA,
USA) was used to evaluate mineral apposition rate (MAR)
(inmm/d) in the frozen sections of tibia and vertebrae according
to standard protocols.(30,31)
Results
HFD-induced obesity decreased trabecular and cortical
bone mass
To determine the effect of obesity on BMAT and bone
metabolism, C57BL/6J male mice were fed with a high-fat diet
(HFD) (60% kcal of fat) for 12 weeks. After 12 weeks, HFD mice
exhibited increased body weight (29%), body fat mass (212%),
and impaired glucose tolerance compared with normal chow
diet mice (ND) (Supplemental Fig. S1A–D).
mCT of proximal tibia showed decreased trabecular bone
volume per total volume (BV/TV) and trabecular number (Tb.N),
and increased trabecular separation (Tb.Sep), whereas trabecu-
lar thickness (Tb.Th) was unchanged in HFDmice comparedwith
ND mice (Fig. 1A). Similarly, cortical bone parameters BV/TV and
thickness were reduced in HFD mice at diaphysis (Fig. 1B) but
unchanged at metaphysis. No change in periosteal circumfer-
ence was detectable (Supplemental Fig. S2A–D). These changes
are demonstrated in representative 3D reconstruction images of
trabecular and cortical bone in ND and HFD mice (Fig. 1C).
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Fig. 1. Bone phenotype of HFDmice. (A–C) mCT analysis of proximal tibia after 12 weeks of HFD and ND as a control. (A) At metaphysis, trabecular bone
parameters were evaluated as bone volume per total volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), and trabecular separation
(Tb.Sep). (B) mCT analysis of cortical diaphysis bone measurements was evaluated as cortical BV/TV (Co.BV/TV) and cortical thickness (Co.Th). (C)
Representative images for mCT 3D reconstruction of trabecular (upper panel) and cortical (lower panel) compartments. Data are presented as
mean SEM (n¼ 32), p< 0.05, p< 0.01; p< 0.001: ND versus HFD. (D) Quantiﬁcation of double calcein labeling of trabecular bone in tibia: mineral
apposition rate (MAR) (left panel) calculated from the distance between the two labeled layers and bone formation rate (BFR) (right panel) calculated as a
function of daily MAR and (E) in vertebrae, respectively, left and right panel from ND and HFD groups (n¼ 6 per group). (F) Representative pictures of
double calcein labeling of vertebrae from animals fed with ND and HFD for 12 weeks. (G) Markers for bone turnover, P1NP (n¼ 15 per group) for bone
formation (left panel) and CTX-1 (n¼ 9 per group) for bone resorption (right panel) were measured in serum. (H) Histomorphometric analysis on bone
sections from ND and HFD tibia (representative sections) after 12 weeks of diet stained with tartrate-resistant acid phosphatase (TRAP) (n¼ 6). (I)
Osteoclast surface per bone surface (OcS/BS%) was evaluated in tibia. Data are presented as mean SEM; p< 0.05: ND versus HFD; two-tailed unpaired
Student’s t test.
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Dynamic bone histomorphometry performed on tibia and
vertebrae showed a trend toward decreased mineral apposition
rate (MAR) and a signiﬁcant decrease in bone formation rate
(BFR) in tibia, whereas both parameters were signiﬁcantly
reduced in the vertebrae of HFD mice (Fig. 1D–F). Moreover,
serum levels of bone formation marker procollagen type 1 N-
terminal propeptide (P1NP) decreased, but bone resorption
marker C-telopeptide of type I collagen (CTX-1) did not change
in HFD mice (Fig. 1G). Similarly, histological analyses of proximal
tibia sections using tartrate-resistant acid phosphatase (TRAP)
staining (Fig. 1H) showed no changes in osteoclasts surface per
total bone surface (Fig. 1I) or number of osteoclasts per total
bone surface (data not shown), suggesting that the osteoclast
activity did not change with HFD.
Bone marrow adipose tissue (BMAT) volume increased in
HFD-induced obesity
To evaluate BMAT volume, BMAT was visualized by osmium-
tetraoxide staining in long bones (tibias) ex vivo after 12 weeks
of HFD. Histological sections of osmium-stained bones demon-
strated the strong afﬁnity of the osmium for BMAT (Fig. 2A). mCT
imaging of osmium tetroxide-stained BMAT revealed increased
BMAT volume in tibia, especially in the proximal metaphysis and
in the distal diaphysis (Fig. 2B–D). In ND mice, most of the BMAT
was present in distal tibia (Fig. 2D). Further, histomorphometric
analysis of hematoxylin-eosin-stained sections of the bones
conﬁrmed a signiﬁcant increase of BM adiposity in proximal tibia
in HFD mice (Fig. 2E, F). These changes in the BM were
accompanied by increased BM adipocyte number and size
(adipocyte area) (Fig. 2G, H). Perilipin staining, a speciﬁc marker
of adipocytes, localized the area of adipocytes (Fig. 2I). In
addition, in the whole group of mice, tibia BMAT volume was
negatively correlated with BV/TV and Tb.N and positively
correlated with Tb.Sep (Supplemental Fig. S3A–C).
HFD-induced obesity altered BM-MSC stemness and
differentiation
To determine the cellularmechanisms of enhanced adipogenesis
and decreased bone mass in obese mice, we ﬁrst examined the
cellular and molecular phenotype of BM-MSC. HFD reduced the
percentage of CD73þ and Sca1/CD140aþ cells in BM-MSC
(Fig. 3A) assuming that the proportion of progenitor populations
changed. The short-term proliferation rate and colony-forming
units-ﬁbroblast (CFU-f) of primary cultureswere decreased inHFD
mice (Fig. 3B,C).Wedidnotﬁndevidence for increasednumber of
senescent cells stained positive for senescence-associated b-
galactosidase, nor for increased levels of senescent genemarkers
(p16, p21) in BM-MSC cultures of HFD mice (Fig. 3D, E). Further,
BM-MSC obtained from HFDmice exhibited increased adipocytic
(AD) differentiation capacity compared with ND mice measured
by mRNA gene expression of adipogenic genes, ie, Pparg2, Lep,
Adipoq, Fsp27 (Fig. 3F). Osteoblast (OB) differentiation of BM-MSC
obtained fromHFDmice revealed increased alkalinephosphatase
(ALP) activity (Fig. 3G). mRNA levels of speciﬁc osteoblastic genes
(ie, Alp, Runx2, Ocn) did not show differences of BM-MSC in HFD
mice compared with ND (Fig. 3H).
HFD-induced obesity did not lead to a pro-inflammatory
BM microenvironment
To investigate the mechanism underlying the BM-MSC changes
in lineage commitment, we examined changes in BM
microenvironment. Because obesity is associated with increased
inﬂammation in peripheral AT, we examined whether obeso-
genic condition in mice has a similar effect on BM microenvi-
ronment. Immunophenotyping showed an altered composition
of immune cells in BM with decreased number of CD19þ B cells
and increased number of CD4þ T lymphocytes as well as CD45þ
hematopoietic cells in HFDmice (Fig. 4A). However, mRNA levels
of inﬂammatory gene markers in HSC revealed decreased
inﬂammatory signature in BM under HFD condition evidenced
by decreased mRNA expression of Il1b, which was more
manifested after 20 weeks of HFD by decreased mRNA levels
of Il6 and Lipocalin 2 (Lcn2) in addition to Il1b (Supplemental
Fig. S4A, B). To conﬁrm the low pro-inﬂammatory phenotype,
isolated CD45þ hematopoietic cells exposed to lipopolysaccha-
ride (LPS) exhibited decreased inﬂammatory responsemeasured
bymRNA levels of Il1b andMcp1 in HFDmice compared with ND
mice (Fig. 4C). In addition, the response to LPS stimulation was
similar in HFD compared with ND mice with a respect to
activation of NF-kB pathway, one of the key inﬂammatory
pathways, as measured by phospho IkBa and p65 activity
(Fig. 4D).
HFD-induced obesity did not exhibit a pro-inflammatory
phenotype of BMAT compared with peripheral adipose
tissue (AT)
Changes in BM microenvironment in response to HFD can be
mediated by the accumulated BMAT. Thus, we characterized the
molecular phenotype of BMAT isolated from long bones in
response to HFD-induced obesity and compared to visceral
adipose tissue (VAT) with known pro-inﬂammatory phenotype
as well as brown adipose tissue (BAT). Under basal conditions of
ND, the gene expression proﬁle of BMAT showed higher mRNA
levels of pro-inﬂammatory genes (Tnfa, Il1b, and Lcn2) compared
with peripheral adipose depot: VAT and BAT (Fig. 5A). In contrast,
genes related to insulin signaling (Insr, Irs1, Igf1) and adipo-
genesis (Pparg2, Ap2, Adipoq, Lep) were highly expressed in VAT
and BAT comparedwith BMAT (Fig. 5B, C). Molecular signature of
BMAT was different from BAT except for Dio2, which showed
similar mRNA levels in BMAT and BAT (Fig. 5D).
In HFD, BMATmanifested increased gene expression of insulin
signaling genes (Insr), adipogenic genes (Adipoq, Lep, Fsp27, C/
ebpa), and decreased pro-inﬂammatory genes (Lcn2) (Supple-
mental Fig. S4B), which was opposite to the phenotype
observed in VAT with decreasedmRNA levels of insulin signaling
genes (Irs1, Irs2, Insr), adipogenic genes (Adipoq, Fsp27, Cidea, C/
ebpa, Pparg2), and increased mRNA levels of pro-inﬂammatory
genes (Tnfa, Il1b, and Lcn2) (Supplemental Fig. S4C). Similar
results with a more pronounced phenotype in BMAT and VAT
were observed after 20 weeks of HFD (Fig. 5E, F).
HFD-induced obesity did not impair insulin sensitivity in
BM-MSC compared with AT-MSC
Insulin resistance accompanies HFD-induced obesity and may
play a role in mediating changes in BM-MSC niche. To test this
hypothesis, we examined insulin signaling and responsiveness
in BM-MSC obtained from HFD mice and compared with AT-
MSC derived from VAT previously shown to exhibit insulin
resistance and inﬂammation in HFD-induced obesity.(32) In
HFD mice, VAT AT-MSC exhibited impaired adipocytic (AD)
differentiation (Supplemental Fig. S5A, B) and under basal
conditions decreased gene expression of Pparg2 and increased
mRNA levels of Tnfa, a marker of inﬂammatory status in AT. On
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the other hand, BM-MSC exhibited increased gene expression
of Pparg2 and decreased gene expression of Tnfa (Fig. 6A, B),
suggesting the opposite metabolic phenotype. In addition,
under HFD insulin-stimulated activation of pAKT(S473)/
totalAKT was decreased in undifferentiated and AD differenti-
ated progeny in VAT AT-MSC, whereas BM-MSC maintained
insulin responsiveness under basal and following AD differen-
tiation (Fig. 6C–F).
Fig. 2. BMAT evaluation in HFD mice. (A) Histological sections of tibia after osmium staining and stained with H&E. Black¼ adipocytes stained by
osmium; scale bar¼ 100mm. (B–D) Quantiﬁcation of the bone marrow adipose tissue (BMAT) volume in (B) full-length tibia (all marrow cavity) and (C)
proximal tibia area (previously evaluated for trabecular parameters) evaluated bymCT from osmium-stained bones. (D) Representative images ofmCT 3D
reconstruction of BMAT from full-length tibia (upper panel) and proximal tibia area (lower panel) of mice fed for 12 weeks with ND or HFD. (E) H&E
staining of histological sections of tibia frommice fed for 12weekswith NDor HFD; scale bar¼ 100mm. (F–H) Histomorphometric evaluation of the BMAT
expressed as (F) adiposity (adipocytes surface per ﬁeld), (G) adipocytes number per ﬁeld, and (H) adipocyte area on H&E sections. (I) Perilipin staining of
histological tibia sections from mice fed for 12 weeks with ND or HFD. Scale bars¼ 100 mm. Data are presented as mean SEM (n¼ 6 per group);
p< 0.05, p< 0.01: ND versus HFD, two-tailed unpaired Student’s t test.
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Fig. 3. Molecular and cellular characteristics of BM-MSC in HFD mice. Primary bone marrow skeletal stem cells (BM-MSC) isolated from mice fed for
12weekswith NDor HFD (A). Screening of stem cell marker expressionmeasured by ﬂow cytometry in primary BM-MSC isolated frommice fedwith NDor
HFD over 12 weeks (n¼ 6). (B) Proliferative capacity of BM-MSC over 9 days in culture (n¼ 4–6). (C) Colony-forming unit properties, (D) senescence
evaluation as SA-b gal activity per cell viability measurement, and (E) gene expression represented as fold change of senescence markers p16 and p21 in
BM-MSC isolated from ND and HFD mice (n¼ 4–6). (F) Adipocyte differentiation potential of the BM-MSC evaluated by gene expression of Pparg2, Lep,
Adipoq, and Fsp27. (G, H) Osteoblast differentiation potential of the BM-MSC evaluated by quantiﬁcation of (G) alkaline phosphatase (ALP) activity
represented as fold change over noninduced cells (day 11) and (H) by gene expression of Alp, Runx2, and Ocn (n¼ 4–6). Data are presented as
mean SEM from three independent experiments. p< 0.05, p< 0.01 compared with ND, two-tailed unpaired Student’s t test.
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Discussion
In the present study, we report that HFD-induced obesity in
mice leads to increased BMAT formation, enhanced AD
differentiation of BM-MSC, and reduced bone mass. Interest-
ingly, BMAT, in contrast to extramedullary adipocytes, did not
exhibit a pro-inﬂammatory phenotype and maintained its
insulin responsiveness. Our study suggests that BMAT
responds to metabolic stimuli and acts as a depot for storing
extra energy during HFD when peripheral AT is incapable of
mediating this function.
HFD-induced obesity led to decreased bone mass and
BMAT expansion
Similar to other investigators studying BMAT in mice and
humans, we observed that HFD increased BMAT formation as
evidenced by increased BMAT volume, adipocyte number, and
size.(3,4,33–37) In addition, we observed signiﬁcant and consis-
tent decrease in trabecular and cortical bone mass after
12 weeks of HFD. Previous studies have reported inconsistent
results regarding the impact of HFD on bone mass and bone
quality. Some studies reported no change or increased or
decreased bone mass with lower bone strength.(33–36,38,39)
These discrepancies can be explained by variations in
experimental models, e.g., mouse strain, sex, length/type/
composition of diet (60% versus 45% fat or 10% corn oil), and
possibly evaluation methods. However, the consistency
observed in our study and some of the previous stud-
ies,(35,37,40,41) as well as the recent study of Bornstein and
colleagues reported HFD induced reduction in the cortical and
trabecular parameters in the long bones along with increased
BMAT volume,(37) suggesting that bone mass reduction is a
biological consequence of coherent mechanisms of cellular
and molecular changes relevant for studies of bone fragility in
human obesity.(42–44)
HFD led to a progenitor cell “exhaustion” and enhanced
adipocyte differentiation
BMAT originate from progenitor cell population within the BM
stroma.(45,46) We observed that HFD-induced obesity increased
BMAT volume and is associated with decreased proliferative
potential of progenitor cells and enhanced differentiation of BM-
MSC into adipocytes. Based on a number of pathophysiological
studies, an inverse relationship between BMAT and bone
Fig. 4. HSC composition and their inﬂammatory status in HFD mice. (A) Immunophenotyping of hematopoietic stem cells (HSC) measured by ﬂow
cytometry in ND andHFDmice (n¼ 3). (B) Gene expression proﬁle represented as fold change of inﬂammatory genes in HSC ofmice fed for 20weekswith
ND or HFD directly after isolation (n¼ 3) (C) or after 3 hours of LPS treatment (100 ng/mL) (n¼ 3). (D) Representative Western blotting to evaluate
phosphorylation of IkBa (p-IkB) and total IkBa and phosphorylation of p65 (p-p65) and total p65 after LPS exposure (15 minutes, 100 ng/mL) in HSC
isolated from ND or HFD mice fed 20 weeks of HFD. Data are presented as mean SEM from three independent experiments. p< 0.05, compared with
ND, two-tailed unpaired Student’s t test.
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formation has been reported,(3,4,47,48) suggesting changes in BM-
MSC commitment to adipocyte versus osteoblast lineage.(49)
Our data support this hypothesis under HFD-induced obesity, as
we observed enhanced adipocyte differentiation in BM-MSC
obtained from HFD mice. Moreover, decreased number of
Sca1þ cells in HFD suggests that the expansion of adipocytic
progenitors (Sca1-) might occur as previously reported.(50) The
decrease in BM-MSC and increased number of committed
adipocytes may be caused by several mechanisms including
changes in the BM-MSC niche due to local and systemic
changes(51) or high-triglyceride load in the circulation increasing
lipid uptake by skeleton.(52)
HFD did not cause an “inflamed” BMAT
We examined for a possible mechanism that links obesity, BMAT
expansion, and decreased bone mass. Obesity is associated
with increased inﬂammation in peripheral AT.(1,22) Our results
Fig. 5. BMAT gene expression proﬁle compared with peripheral adipose depots in lean and HFD condition. (A–D) Gene expression proﬁle in different
adipose depots BMAT, VAT, and BAT in NDmice: (A) inﬂammatory genes as Tnfa, Il1b,Mcp1, and Lcn2, (B) insulin signaling-related genes as Insr, Irs1, and
Igf1, (C) adipogenic genes as Pparg2, aP2, Adipoq, and Lep and (D) brown fat-related genes asUcp1, Pgc1a, Prdm16, andDio2 (n¼ 3). (E) Impact of 20weeks
of HFD on the gene expression proﬁle in BMAT and (F) VAT (n¼ 6). Data are presented asmean SEM (p< 0.05, p< 0.01, p< 0.001: ND versus HFD,
one-way analysis of variance (ANOVA) for A–D and two-tailed unpaired Student’s t test for E–F).
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demonstrated that after HFD, BMAT does not develop a “pro-
inﬂammatory” phenotype similar to that observed in peripheral
AT with impaired adipogenesis and insulin signaling along with
increased inﬂammation.(22) In contrast to previous studies(20)
that examined BMAT as part of the heterogeneous bone tissue,
we isolated BMAT directly from long bones, which enhanced the
internal validity of our study and point out that decreased bone
mass is not the result of “inﬂamed” BMAT.
Fig. 6. Comparison of BM-MSC to AT-MSC in relation to adipogenesis and insulin responsiveness in HFD mice. Impact of HFD on the gene expression
proﬁle represented as fold change in (A) BM-MSC and (B) AT-MSC from VAT (n¼ 3). (C, D) Representative Western blot to evaluate insulin-stimulated
(100 nM, 15minutes) phosphorylation of AKT (p-S473AKT) and total AKT in undifferentiated and AD differentiated (C) BM-MSC and (D) AT-MSC from VAT
(n¼ 2–3). (E, F) Densitometry evaluation of Western blot measuring insulin stimulation (100 nM) of AKT as p-S473-AKT/total AKT in undifferentiated and
differentiated cells from (E) BM-MSC and (F) AT-MSC from VAT (n¼ 2–3). Data are presented as mean SEM from three independent experiments
(p< 0.05, p< 0.01: ND versus HFD, two-tailed unpaired Student’s t test).
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HFD did not lead to a “pro-inflammatory” BM
microenvironment
BMAT and its progenitors exist within a close proximity to
hematopoietic marrow. Previous studies reported obesity-
induced impairment of hematopoiesis, including depletion of
B lymphocytes and changes in HSC niche.(16,53,54) We observed
decreased B lymphopoiesis and increased CD4þ T lymphocyte
and CD45þ/CD34- HSC populations in HFDmice. These changes
may be attributed to changes in adipokine secretion, having
inhibitory effects on HSC proliferation and differentia-
tion.(17,19,50) In vitro studies showed that adipocyte-derived
factors such as adiponectin could impair B lymphopoiesis and
increase myelopoiesis.(55,56) Indeed, in our study, we observed
increased levels of adiponectin in BMAT alongwith decreased B-
lymphocyte population. In addition, LPS responsiveness in HSC
exposed to the HFD environment was impaired, suggesting the
presence of a “protective” mechanism against BM inﬂammation
during the initial phases of BMAT expansion in obesity. Future
studies need to determine the anti-inﬂammatory mechanisms
and its relevance to the BMAT biology.
BMAT maintains an insulin-responsive phenotype in
HFD-induced obesity
The physiology of BMAT and its contribution to whole-body
metabolism is still not well understood. In the present study, the
molecular and cellular data on BMAT phenotype with increased
expression of insulin-responsive genes raised a question
whether BMAT insulin signaling is affected by obesity similar
to peripheral AT. Recent animal studies revealed that insulin-
regulated glucose uptake in the skeleton measured by PET
scanning was decreased under HFD, suggesting the presence of
insulin resistance.(23,24,57)However, in these studies, they did not
distinguish BMAT from the rest of the BM. Our ﬁndings in BMSC
and BMAT point out that BMAT is a “metabolically responsive”
tissue in HFD, and contrary to peripheral extramedullary AT, it
may respond to increased metabolic demand coming from the
BM microenvironment and serves as a buffering organ for
excessive energy. However, longer exposure to HFD might
switch the BMAT metabolic phenotype with a worse impact on
bone. This needs to be addressed in future studies.
There are some limitations in our study. First, there may be a
risk that the isolated BMAT preparations were contaminated
with hematopoietic cells, which affects the molecular analysis of
BMAT phenotype. However, we observed no difference in the
number of CD45þ cells in BMAT preparations obtained from ND
and HFD mice, suggesting the absence of signiﬁcant hemato-
poietic cell contamination. The presence of hematopoietic cells
would have increased the levels of pro-inﬂammatory cytokines,
whereas we observed a decrease in their levels. Second, we
employed collagenase digestion in cell isolation procedures,
which may activate several inﬂammatory pathways. However,
we employed collagenase isolation in both BM-MSC and AT-
MSC, and the cells were cultured under identical conditions for
several days, minimizing the confounding effects of collagenase
on inﬂammation-associated gene expression. Third, in our study,
we employed male mice because they are more prone to
obesity-induced metabolic complications.(58,59) However, stud-
ies of female mice need to be performed to generalize our
ﬁndings.
HFD-induced obesity in mice led to decreased bone mass,
which is different from the observed increase in bone mass in
obese humans, limiting the translational relevance of our study.
However, BMAT expansion is a consistent ﬁnding in HFD mice
Fig. 7. Aworkingmodel for the effects of HFD-induced obesity on BMAT compared with peripheral AT. In HFD condition and compared with peripheral
adipose tissue (AT), bone marrow microenvironment exhibits decreased inﬂammatory response of hematopoietic cells (HC) and adipocytic progenitors
as well as maintenance of insulin signaling leading to enhanced adipogenesis. Peripheral AT exhibits higher levels of inﬂammation and impaired insulin
signaling. The BMAT expansion can thus serve to buffer excess energy from HFD. This results in decreased osteoblast recruitment and consequently
decreased bone formation.
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and in obese humans.(4,60) Thus, our study is relevant to the
understanding the cellular, molecular, and metabolic conse-
quences of increased bone marrow adipogenesis and provides
insight into the possible mechanisms of bone fragility observed
in obese humans.
In summary (Fig. 7), the present study proposes a model for
the relationship between increased BMAT and decreased bone
mass after HFD feeding. The absence of inﬂammation and
continuous recruitment of pre-adipocytic cells from BM-MSC to
buffer the excess calories leads to stem cell exhaustion and
impaired osteoblast recruitment and bone formation. Impor-
tantly, our ﬁndings demonstrate the presence of a metabolically
healthy BMAT capable of responding tometabolic demands in a
low-inﬂammatory BM microenvironment, which is opposite to
what is observed in peripheral AT, suggesting an unexpected
role of BMAT in obesity and providing possible strategies for a
treatment of obesity-induced bone fragility.
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